Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Schizophrenia, Paranoid

• Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
• Research Into Antipsychotic Discontinuation and Reduction Trial
• D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
• Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
• Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
• Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)
• Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
• Anticholinergic Burden in Schizophrenia
• A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
• Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
• MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
• MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)